Skip to main content
Chemosensitivity helps predict survival outcomes after CAR T-cell therapy for DLBCL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Chemosensitivity helps predict survival outcomes after CAR T-cell therapy for DLBCL
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Hodgkin Lymphoma (NHL)
1
1
Biologic Therapy
0
1
CAR-T
0
0.88
Chemotherapy
0
0.95
Refractory
0
0.85
B-Cell Lymphoma
0
1
Cell Transplantation
0
0.21
Lymphoma
0
0.2
Cancer
0
0.1
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.86
Edit Tags